What's Happening?
Six Cornell University research teams have received $292,869 in Ignite Innovation Acceleration funding to advance their projects toward commercialization. This program, managed by Cornell's Center for Technology Licensing (CTL), provides milestone-driven
grants to prepare early-stage technologies for licensing, startup formation, or industry collaboration. Among the funded projects are a virus-delivered treatment to combat Salmonella in chickens and a light-powered carbon capture method. Erick Maosa's team developed a treatment that disarms Salmonella by shutting down its gut invasion machinery using a natural fatty acid, delivered by a virus that specifically targets Salmonella. Professor Phillip Milner's lab created a carbon capture method that uses only sunlight, eliminating the need for costly heating or pressurizing steps, by using different light colors to capture and release CO2.
Why It's Important?
These Cornell innovations have significant implications for U.S. industries and public health. The Salmonella treatment for broiler chickens addresses a major food safety concern, as Salmonella causes approximately 1.3 million infections and 500 deaths annually in the U.S. The broiler chicken industry faces millions in recall costs due to contamination, and this low-cost, easy-to-administer solution could provide an economically viable control method where none currently exist. This would reduce industry losses and enhance consumer safety. The light-powered carbon capture technology offers a potentially affordable and energy-efficient solution for reducing CO2 emissions from industrial sources like cement and steel plants, and even direct air capture. This could help the U.S. meet climate goals and create new markets for carbon capture technologies, especially in sectors where current methods are too expensive.
What's Next?
The Cornell teams will use the Ignite funding to achieve specific milestones that increase their technologies' chances of commercialization. This includes generating proof-of-concept data, building prototypes, conducting early market research, and preparing regulatory submissions. For the Salmonella treatment, the next steps involve further development and potential commercialization, with the aim of integrating it into poultry farming practices, possibly by adding it to chicks' drinking water. The carbon capture technology will focus on demonstrating market readiness and exploring applications in various industrial settings, potentially leading to passive, low-cost carbon capture units. The CTL will continue to evaluate the progress of these projects, looking for licensing agreements, new ventures, or industry partnerships to bring these innovations to market.
Beyond the Headlines
The funding of these diverse projects highlights Cornell University's role as a hub for innovation addressing critical societal challenges, from food safety and public health to climate change. The Salmonella treatment represents a novel approach to combating antibiotic resistance by disarming bacteria rather than killing them, which could have broader implications for infectious disease control. The light-powered carbon capture technology could be a game-changer in the fight against climate change, making carbon capture more accessible and economically feasible for a wider range of industries and even for passive environmental remediation. These innovations underscore the long-term impact of university research in driving technological advancements that benefit both the economy and public well-being, potentially leading to new industries and job creation in the U.S.
